蟾蜍灵通过程序性坏死途径诱导人胃癌细胞SGC-7901死亡

doi:10.3969/j.issn.1006-7795.2019.02.018

首都医科大学学报 ›› 2019, Vol. 40 ›› Issue (2): 251-256.doi: 10.3969/j.issn.1006-7795.2019.02.018

蟾蜍灵通过程序性坏死途径诱导人胃癌细胞SGC-7901死亡

宫鹏超¹, 李艳兰¹, 孔翠翠², 田昕¹

1. 中国医科大学附属第一医院肿瘤研究所二室, 沈阳 110001;
2. 中国医科大学肿瘤医院中心试验室, 沈阳 110001

收稿日期:2018-05-22 出版日期:2019-03-21 发布日期:2019-04-15
通讯作者: 田昕 E-mail:tianxin@cmu1h.com
基金资助:
国家自然科学基金（8157140503）。

Bufalin induces necroptosis in human gastric cancer SGC-7901 cells

Gong Pengchao¹, Li Yanlan¹, Kong Cuicui², Tian Xin¹

1. Molecular Oncology Laboratory of Cancer Research Institute, The First Affiliated Hospital of China Medical University, Shenyang 110001, China;
2. Department of Central Laboratory, The Cancer Hospital of China Medical University, Shenyang 110001, China

Received:2018-05-22 Online:2019-03-21 Published:2019-04-15
Supported by:
This study was supported by National Natural Science Foundation of China(8157140503).

摘要/Abstract

摘要： 目的探讨蟾蜍灵（Bufalin）诱导人胃癌SGC-7901细胞死亡过程中程序性坏死途径的发生机制。方法体外培养SGC-7901细胞，于对照组加入RPMI 1640培养液，实验组加入不同浓度的蟾蜍灵（50、100、150、200 nmol/L），对照组与实验组细胞继续培养48 h。MTT法检测细胞活性，DAPI染色法观察细胞核形态改变，透射电镜观察细胞膜及细胞核改变，流式细胞术检测细胞坏死率，Western blotting法检测程序性坏死关键蛋白受体相互作用蛋白激酶1（receptor interacting protein kinase 1，RIP1）的表达。结果 MTT实验结果表明，蟾蜍灵对SGC-7901细胞的生长具有显著的抑制作用（P<0.05）。通过透射电镜可以观察到细胞坏死时的特征性改变，如细胞膜破裂、细胞内空泡的产生以及细胞器的崩解。DAPI染色显示，蟾蜍灵（100 nmol/L）处理细胞48 h后，无明显细胞凋亡特征性改变，如细胞核固缩、核碎裂、凋亡小体形成。与对照组相比细胞坏死率升高（P<0.05）。蟾蜍灵对程序性坏死途径关键蛋白RIP1的表达有促进作用（P<0.05）。结论蟾蜍灵通过程序性坏死途径诱导SGC-7901细胞死亡。

关键词: 蟾蜍灵, 人胃癌细胞, 程序性坏死

Abstract: Objective To investigate the necroptosis mechanism induced by Bufalin in human gastric cancer SGC-7901 cells. Methods SGC-7901 cells were cultured in vitro. The cells in the control group were cultured in RPMI 1640 medium, while those in the experimental group were exposed to various concentrations of Bufalin(50,100,150,200 nmol/L). After treatment for 48 h, the cell survival rate was assessed by MTT assay. Cell ultrastructures were observed by transmission electron microscope. Morphological changes in the nuclei were observed by DAPI fluorescence staining. Cellular necroptosis was assayed by flow cytometry. Western blotting was used to analyze the expression of receptor interacting protein kinase 1 (RIP1) in the necroptosis pathway. Results MTT assay showed that Bufalin had a significant effect on the growth of SGC-7901 cells(P<0.05). Transmission electron microscopy can be used to observe characteristic changes in cell necrosis, such as disruption of cell membranes, production of intracellular vacuoles, and disintegration of organelles. DAPI staining showed that after treatment with 100 nmol/L for 48 h, there were no obvious changes in cell apoptosis, such as nuclear condensation, nuclear fragmentation and formation of apoptotic bodies. The cell necrosis rate was higher than control group(P<0.05). Bufalin promotes the expression of RIP1, a key protein of necroptosis pathway(P<0.05). Conclusion Bufalin efficiently induced cell death through necroptosis pathway in SGC-7901 cells.

Key words: Bufalin, human gastric cancer cell, necroptosis

中图分类号:

R735.2

宫鹏超, 李艳兰, 孔翠翠, 田昕. 蟾蜍灵通过程序性坏死途径诱导人胃癌细胞SGC-7901死亡[J]. 首都医科大学学报, 2019, 40(2): 251-256.

Gong Pengchao, Li Yanlan, Kong Cuicui, Tian Xin. Bufalin induces necroptosis in human gastric cancer SGC-7901 cells[J]. Journal of Capital Medical University, 2019, 40(2): 251-256.

参考文献

[1] Fulda S. Tumor resistance to apoptosis[J]. Int J Cancer, 2009, 124(3):511-515.
[2] Zhang Y Y, Liu H. Connections between various trigger factors and the RIP1/RIP3 signaling pathway involved in necroptosis[J]. Asian Paci J Cancer Prev APJCP, 2013, 14(12):7069-7074.
[3] Hu F, Han J, Zhai B, et al. Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation[J]. Apoptosis, 2014, 19(1):210-223.
[4] Shen S, Zhang Y, Wang Z, et al. Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress[J]. Int J Biol Sci, 2014, 10(2):212-224.
[5] Videira M, Reis R L, Brito M A. Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance[J]. Biochim Biophys Acta, 2014, 1846(2):312-325.
[6] Viktorsson K, Lewensohn R, Zhivotovsky B. Apoptotic pathways and therapy resistance in human malignancies[J]. Adv Cancer Res, 2005, 94:143-96.
[7] Ellis L M, Bernstein D S, Voest E E, et al. American society of clinical oncology perspective:raising the bar for clinical trials by defining clinically meaningful outcomes[J]. J Clin Oncol, 2014, 32(12):1277-1280.
[8] Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury[J]. Nat Chem Biol, 2005, 1(2):112-119.
[9] Hu X, Han W, Li L. Targeting the weak point of cancer by induction of necroptosis[J]. Autophagy, 2007, 3(5):490-492.
[10] Grassilli E, Narloch R, Federzoni E, et al. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy[J]. Clin Cancer Res, 2013, 19(14):3820-3831.
[11] Fayaz S M, Suvanish Kumar V S, Rajanikant G K. Necroptosis:who knew there were so many interesting ways to die?[J]. CNS Neurol Disord Drug Targets, 2014, 13(1):42-51.
[12] Feoktistova M, Leverkus M. Programmed necrosis and necroptosis signalling[J]. FEBS J, 2015, 282(1):19-31.
[13] Linkermann A, Green D R. Necroptosis[J]. New Engl J Med, 2014, 370(5):455-465.
[14] He S, Wang L, Miao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha[J]. Cell, 2009, 137(6):1100-1111.
[15] Xie T, Peng W, Liu Y, et al. Structural basis of RIP1 inhibition by necrostatins[J]. Structure, 2013, 21(3):493-499.
[16] 李冬阳,李智,曲晶磊,等.NF-κB活化受体因子在胃癌中的表达及临床意义[J].中国医科大学学报,2018,47(10):881-885,890.

蟾蜍灵通过程序性坏死途径诱导人胃癌细胞SGC-7901死亡

Bufalin induces necroptosis in human gastric cancer SGC-7901 cells

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价